Nobilis Influenza H5N2

RSS

Authorised

This medicine is authorised for use in the European Union

adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5
MedicineVeterinaryAuthorised

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

български (BG) (93.36 KB - PDF)

Skoða

español (ES) (81.97 KB - PDF)

Skoða

čeština (CS) (93.99 KB - PDF)

Skoða

dansk (DA) (83.34 KB - PDF)

Skoða

Deutsch (DE) (82.76 KB - PDF)

Skoða

eesti (ET) (82.18 KB - PDF)

Skoða

ελληνικά (EL) (93.76 KB - PDF)

Skoða

français (FR) (82.44 KB - PDF)

Skoða

Gaeilge (GA) (83.57 KB - PDF)

Skoða

hrvatski (HR) (92.27 KB - PDF)

Skoða

italiano (IT) (82.29 KB - PDF)

Skoða

latviešu (LV) (94.29 KB - PDF)

Skoða

lietuvių (LT) (94.03 KB - PDF)

Skoða

magyar (HU) (94.15 KB - PDF)

Skoða

Malti (MT) (95.95 KB - PDF)

Skoða

Nederlands (NL) (82.05 KB - PDF)

Skoða

polski (PL) (95.62 KB - PDF)

Skoða

português (PT) (83.01 KB - PDF)

Skoða

română (RO) (94.17 KB - PDF)

Skoða

slovenčina (SK) (94.08 KB - PDF)

Skoða

slovenščina (SL) (82.27 KB - PDF)

Skoða

suomi (FI) (81.54 KB - PDF)

Skoða

svenska (SV) (82.05 KB - PDF)

Skoða

Íslenska (IS) (83.29 KB - PDF)

Skoða

norsk (NO) (82 KB - PDF)

Skoða

Product information

български (BG) (91.78 KB - PDF)

Skoða

español (ES) (81.51 KB - PDF)

Skoða

čeština (CS) (92.48 KB - PDF)

Skoða

dansk (DA) (82.05 KB - PDF)

Skoða

Deutsch (DE) (81.72 KB - PDF)

Skoða

eesti (ET) (81.22 KB - PDF)

Skoða

ελληνικά (EL) (91.79 KB - PDF)

Skoða

français (FR) (81.63 KB - PDF)

Skoða

Gaeilge (GA) (81.36 KB - PDF)

Skoða

hrvatski (HR) (91.56 KB - PDF)

Skoða

italiano (IT) (81.76 KB - PDF)

Skoða

latviešu (LV) (92.14 KB - PDF)

Skoða

lietuvių (LT) (92.19 KB - PDF)

Skoða

magyar (HU) (92.76 KB - PDF)

Skoða

Malti (MT) (93.86 KB - PDF)

Skoða

Nederlands (NL) (81.15 KB - PDF)

Skoða

polski (PL) (93.22 KB - PDF)

Skoða

português (PT) (82.53 KB - PDF)

Skoða

română (RO) (91.73 KB - PDF)

Skoða

slovenčina (SK) (81.75 KB - PDF)

Skoða

slovenščina (SL) (81.76 KB - PDF)

Skoða

suomi (FI) (81.11 KB - PDF)

Skoða

svenska (SV) (81.47 KB - PDF)

Skoða

Íslenska (IS) (81.52 KB - PDF)

Skoða

norsk (NO) (81.52 KB - PDF)

Skoða
Latest procedure affecting product information:IG/1348
18/03/2021

български (BG) (93.36 KB - PDF)

Skoða

español (ES) (81.97 KB - PDF)

Skoða

čeština (CS) (93.99 KB - PDF)

Skoða

dansk (DA) (83.34 KB - PDF)

Skoða

Deutsch (DE) (82.76 KB - PDF)

Skoða

eesti (ET) (82.18 KB - PDF)

Skoða

ελληνικά (EL) (93.76 KB - PDF)

Skoða

français (FR) (82.44 KB - PDF)

Skoða

Gaeilge (GA) (83.57 KB - PDF)

Skoða

hrvatski (HR) (92.27 KB - PDF)

Skoða

italiano (IT) (82.29 KB - PDF)

Skoða

latviešu (LV) (94.29 KB - PDF)

Skoða

lietuvių (LT) (94.03 KB - PDF)

Skoða

magyar (HU) (94.15 KB - PDF)

Skoða

Malti (MT) (95.95 KB - PDF)

Skoða

Nederlands (NL) (82.05 KB - PDF)

Skoða

polski (PL) (95.62 KB - PDF)

Skoða

português (PT) (83.01 KB - PDF)

Skoða

română (RO) (94.17 KB - PDF)

Skoða

slovenčina (SK) (94.08 KB - PDF)

Skoða

slovenščina (SL) (82.27 KB - PDF)

Skoða

suomi (FI) (81.54 KB - PDF)

Skoða

svenska (SV) (82.05 KB - PDF)

Skoða

Íslenska (IS) (83.29 KB - PDF)

Skoða

norsk (NO) (82 KB - PDF)

Skoða

Product details

Name of medicine
Nobilis Influenza H5N2
Active substance
inactivated whole avian influenza virus antigen of H5N2 subtype (strain A/duck/Potsdam/1402/86)
International non-proprietary name (INN) or common name
adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5

Authorisation details

EMA product number
EMEA/V/C/000118

Accelerated assessment

This medicine had an accelerated assessment. This means that it is a medicine of major interest for public health, so its timeframe for review was 150 evaluation days rather than 210. For more information, see Accelerated assessment.

Assessment history

български (BG) (93.36 KB - PDF)

Skoða

español (ES) (81.97 KB - PDF)

Skoða

čeština (CS) (93.99 KB - PDF)

Skoða

dansk (DA) (83.34 KB - PDF)

Skoða

Deutsch (DE) (82.76 KB - PDF)

Skoða

eesti (ET) (82.18 KB - PDF)

Skoða

ελληνικά (EL) (93.76 KB - PDF)

Skoða

français (FR) (82.44 KB - PDF)

Skoða

Gaeilge (GA) (83.57 KB - PDF)

Skoða

hrvatski (HR) (92.27 KB - PDF)

Skoða

italiano (IT) (82.29 KB - PDF)

Skoða

latviešu (LV) (94.29 KB - PDF)

Skoða

lietuvių (LT) (94.03 KB - PDF)

Skoða

magyar (HU) (94.15 KB - PDF)

Skoða

Malti (MT) (95.95 KB - PDF)

Skoða

Nederlands (NL) (82.05 KB - PDF)

Skoða

polski (PL) (95.62 KB - PDF)

Skoða

português (PT) (83.01 KB - PDF)

Skoða

română (RO) (94.17 KB - PDF)

Skoða

slovenčina (SK) (94.08 KB - PDF)

Skoða

slovenščina (SL) (82.27 KB - PDF)

Skoða

suomi (FI) (81.54 KB - PDF)

Skoða

svenska (SV) (82.05 KB - PDF)

Skoða

Íslenska (IS) (83.29 KB - PDF)

Skoða

norsk (NO) (82 KB - PDF)

Skoða

български (BG) (91.78 KB - PDF)

Skoða

español (ES) (81.51 KB - PDF)

Skoða

čeština (CS) (92.48 KB - PDF)

Skoða

dansk (DA) (82.05 KB - PDF)

Skoða

Deutsch (DE) (81.72 KB - PDF)

Skoða

eesti (ET) (81.22 KB - PDF)

Skoða

ελληνικά (EL) (91.79 KB - PDF)

Skoða

français (FR) (81.63 KB - PDF)

Skoða

Gaeilge (GA) (81.36 KB - PDF)

Skoða

hrvatski (HR) (91.56 KB - PDF)

Skoða

italiano (IT) (81.76 KB - PDF)

Skoða

latviešu (LV) (92.14 KB - PDF)

Skoða

lietuvių (LT) (92.19 KB - PDF)

Skoða

magyar (HU) (92.76 KB - PDF)

Skoða

Malti (MT) (93.86 KB - PDF)

Skoða

Nederlands (NL) (81.15 KB - PDF)

Skoða

polski (PL) (93.22 KB - PDF)

Skoða

português (PT) (82.53 KB - PDF)

Skoða

română (RO) (91.73 KB - PDF)

Skoða

slovenčina (SK) (81.75 KB - PDF)

Skoða

slovenščina (SL) (81.76 KB - PDF)

Skoða

suomi (FI) (81.11 KB - PDF)

Skoða

svenska (SV) (81.47 KB - PDF)

Skoða

Íslenska (IS) (81.52 KB - PDF)

Skoða

norsk (NO) (81.52 KB - PDF)

Skoða
This page was last updated on

Share this page